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l14th International Congress on Infectious Diseases (ICID) Abs
managed as DHF. Mortality rate amongst dengue IgM posi-
tives was 6.02% (5/83).
Conclusion: The unusual clinical proﬁle necessitates
continuous sero surveillance and monitoring for changing
clinical presentationof dengue infection.
doi:10.1016/j.ijid.2010.02.1873
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Background: In September 2008, an outbreak of pneumo-
nia associated with a rare human adenovirus (serotype-14
[HAdV-14]) occurred on a rural island in Southeast Alaska.
To determine risk factors for disease and household trans-
mission characteristics, we investigated pneumonia cases in
three affected island communities.
Methods: Case-patients were island residents who pre-
sented to one of two medical clinics with clinical or
radiological evidence of pneumonia between September 1
and October 27, 2008. Controls from the community were
matched 1:1 to case-patients based on age, sex, and com-
munity of residence. Case-patients, controls, and household
contacts were interviewed for information on demograph-
ics, recent illnesses, medical history, ill contacts, and other
possible exposures. Serum and respiratory specimens were
also collected. Risk factors for pneumonia were determined
using exact multivariate conditional logistic regression.
Household HAdV-14 attack rates were calculated.
Results: Thirty-two pneumonia case-patients and 32
matched controls were interviewed. Among case-patients,
the median age was 47.5 (range, 2-95 years), 75% were
male, and 74% were Alaska Native. Nine cases resulted
in hospitalization and there was one death. Twenty-one
(66%) case-patients and no controls were infected with
HAdV-14 (p < 0.001). Independent risk factors for pneu-
monia were contact with a known HAdV-14 pneumonia
case-patient (OR = 18.3, 95%CI = 2.0-&), current smoking
(OR = 6.7, 95%CI = 0.9-&), and having neither traveled off-
island nor attended at a large public gathering (OR = 14.7,
95%CI = 2.0-&). Fourteen (67%) of the 21 HAdV-14-infected
case-patients belonged to a single network of people who
socialized and often smoked together and infrequently trav-
eled off-island. HAdV-14 infection occurred in 43% of case-
versus 5% of control-household contacts (p = 0.005).
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Conclusion: This is one of the ﬁrst recognized civil-
an community outbreaks of HAdV-14 since the virus ﬁrst
ppeared in California in 2003. Demographic characteristics
nd illness patterns in case-patients were similar to those
bserved in other HAdV-14 outbreaks in Oregon and Wash-
ngton State in 2007, with disease mostly occurring in adult
ale smokers. In this setting, HAdV-14 appeared to have
pread mostly among close contacts in the home or within
certain social network whose members often reported
moking or sharing smoking materials with other HAdV-14
ase-patients. Lack of HAdV-14 infection in controls and
heir household contacts suggests wide-spread transmission
id not occur, either previously or during this pneumonia
utbreak.
oi:10.1016/j.ijid.2010.02.1874
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Background: In 2006 and 2008, two new vaccines were
ecommended for routine vaccination of US infants against
otavirus. We assessed vaccine uptake and its impact on
otavirus disease in US children.
Methods: To measure vaccine uptake, we examined data
rom sentinel immunization information system (IIS) sites
n eight different US locations. Coverage with at least 1
ose of rotavirus vaccine was measured at age 5 months,
nd compared with coverage of other established child-
ood vaccines, DTaP and pneumococcal vaccine, given at the
ame age. To measure vaccine impact, we examined data
rom 2000-2009 on laboratory detections of rotavirus from
national network of ∼70 laboratories to assess trends and
iming of rotavirus activity. Data from a subset of 29 labo-
atories that consistently reported for ≥30 weeks for each
eason during 2000-2009 were used to measure national and
egional changes in rotavirus test results.
Results: By March 2009, coverage with 1 dose of rotavirus
t age 5 months has reached about 60%-70% across most
f the IIS sites, a level that is about 10%-20% lower than
hat of DTaP and pneumococcal vaccine. Concurrent with
ncreasing rotavirus vaccine coverage, rotavirus activity dur-
ng the 2007-2008 and 2008-2009 rotavirus seasons declined
y 64% and 60%, respectively, compared with pre-vaccine
ears during 2000-2006. In addition, compared with prevac-
ine years, the onset of both the 2007-2008 and 2008-2009
otavirus seasons was delayed by 11 weeks and 6 weeks,
espectively, and the seasons were shorter, lasting 14 and 17
eeks, respectively, compared with 26 weeks in 2000-2006.
egional differences in rotavirus activity were observed,
ith the West census region having a lower reduction and
ess delayed onset than all other regions in 2007-2008 and a
reater reduction andmore delayed onset than other regions
n 2008-2009.
Conclusion: Uptake of rotavirus vaccine in US chil-
ren has increased since vaccine implementation. However,
